Here is a word that’s associated with diabetes that you might not know — microangiopathy. This problem affects between 10-15% of all diabetes patients and is often overlooked, even though it is very simple to diagnose. If you want to know what this condition is and how to diagnose it, then check out this week’s Clinical Text.
Editor’s Note, DCMS #220
SGLT-2 inhibitors and GLP-1 analogs have been the most popular new drugs in the press this year, and we have always brought you the best information on them. In this week’s Homerun Slides and Mastery In Minutes video, Dr. Stanley Schwartz makes the connection between GLP-1, Heart Disease and Hypoglycemia, and we also have an article from the over 15,000 items we have published that contains the scientific basics of how SGLT-2 inhibitors work. For our featured Diabetes Disaster Averted, our Associate Medical Editor, Joy Pape, has another perfect example of why it is so important to have your patients demonstrate their insulin administration techniques, and how this can improve patients’ quality of life.